The pivotal role of DAX-1 expression in EWS/FLI1-mediated oncogenesis suggests that targeting DAX-1 could be a compelling therapeutic strategy for Ewing sarcoma. This evidence concerns the gene NR0B1 and Ewing sarcoma.